Media

Support Of Industry Underscores Pro-Business Commitment
Commercialization of cleaner, safer consumer products through innovative industrial biotechnology processes will be the focus of breakout sessions at the...

Press Releases

May 8 2001
WASHINGTON, D.C. (May 8, 2001) – Biotechnology Industry Organization (BIO) President Carl B. Feldbaum said today that HCFA’s proposed “New Technology” rule for...
May 4 2001
WASHINGTON, D.C. (May 4, 2001) -Government officials from around the world were in Ottawa this week for the meeting of the Codex Committee on Food Labeling (...
May 3 2001
A CAPITOL HILL LUNCH & BRIEFING:BIOTECHNOLOGY'S IMPACT ON DISEASES OF THE ELDERLY FRIDAY, MAY 4, 2001 - 562 DIRKSEN SENATE OFFICE BUILDING WASHINGTON, D.C...
Apr 26 2001
WASHINGTON, D.C. (April 26, 2001)The BiotechnologyIndustry Organization (BIO) today announced three headlining speakers for BIO 2001 in San Diego. Two...
Apr 16 2001
TIRED OF THE SAME OLD EARTH DAY STORIES? To: Environment and Earth Science Reporters Contact: Brent Erickson or Peper Long Biotechnology Industry Organization...
Apr 5 2001
MEMORANDUM April 5, 2001 TO: Editors and reporters covering biotechnology FROM: Dan Eramian, Vice President Communications RE: Cloning The issue of cloning is...
Apr 4 2001
WASHINGTON, D.C. (April 4, 2001) - Carl B. Feldbaum, president of the Biotechnology Industry organization (BIO), today issued the following statement to all...
Mar 27 2001
Washington, D.C. (March 27, 2001) –The Energy and Commerce Subcommittee on Oversight and Investigations will hold a hearing on issues raised by the prospect of...
Mar 23 2001
“BIO AsiaPacific”April 18-19, 2001Sheraton Waikiki, Honolulu, Hawaii WASHINGTON, D.C. (March 23, 2001) – The Biotechnology Industry Organization (BIO) today...


Biotechnology News

September 20, 2014

MONT-TREMBLANT, Quebec--(BUSINESS WIRE)--FibroGen, Inc. (FibroGen) announced today the presentation of the full data set from a clinical study of patients with idiopathic...

September 19, 2014

LOS ANGELES--(BUSINESS WIRE)--Contact Glancy Binkow & Goldberg LLP if you purchased PDL BioPharma, Inc. securities between November 6, 2013 and September 16, 2014.

September 19, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a...

September 19, 2014

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research will present at BioCentury’s 21st Annual NewsMakers in the Biotech Industry conference on September 26, 2014 at 10:30...

September 19, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: Onxeo SA (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ OMX Copenhagen - ONXEO), an innovative...